HomeInsightsStock Comparison

Indoco Remedies Ltd vs Influx Healthtech Ltd Stock Comparison

Indoco Remedies Ltd vs Influx Healthtech Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 337.45 as of 04 Jul 15:30.
  • The P/E Ratio of Indoco Remedies Ltd changed from 79.9 on March 2020 to 30.8 on March 2024 . This represents a CAGR of -17.36% over 5 yearsThe P/E Ratio of Influx Healthtech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Indoco Remedies Ltd changed from ₹ 1929 crore on March 2020 to ₹ 3027 crore on March 2024 . This represents a CAGR of 9.43% over 5 yearsThe Market Cap of Influx Healthtech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Indoco Remedies Ltd for the Mar '25 is ₹ 392.23 crore as compare to the Dec '24 revenue of ₹ 412.39 crore. This represent the decline of -4.89% The revenue of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Indoco Remedies Ltd for the Mar '25 is ₹ 1.24 crore as compare to the Dec '24 ebitda of ₹ 13.87 crore. This represent the decline of -91.06% The ebitda of Influx Healthtech Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Indoco Remedies Ltd changed from ₹ 24.18 crore to ₹ -41.34 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Indoco Remedies Ltd changed from 11.4 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Influx Healthtech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

About Influx Healthtech Ltd

  • Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
  • Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai. Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.

Indoco Remedies Ltd News Hub

News

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug

Allopurinol is used to prevent or lower high uric acid levels in the blood. It is also use...

Read more

23 May 2025 11:34

News

Indoco Remedies receives USFDA final approval for Allopurinol Tablets

 Indoco Remedies announced final approval of Allopurinol Tablets USP, 200 mg through Compa...

Read more

23 May 2025 11:50

News

Board of Indoco Remedies recommends final dividend

Indoco Remedies announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:09

News

Indoco Remedies to conduct board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 15:46

News

Indoco Remedies Ltd leads losers in 'B' group

Premier Energies Ltd, Shiva Texyarn Ltd, Waaree Energies Ltd and Khandwala Securities Ltd ...

Read more

22 Jan 2025 14:45

News

Indoco Remedies slides on recording dismal Q3 numbers in FY25

Revenue from operations stood at Rs 364.91 crore in the third quarter of FY25, down 18.61%...

Read more

21 Jan 2025 12:53

Influx Healthtech Ltd News Hub

News

NSE SME Influx Healthtech makes a strong debut

The scrip was listed at Rs 132.50, a premium of 38.02% compared with the initial public of...

Read more

25 Jun 2025 11:42

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Indoco Remedies Ltd and Influx Healthtech Ltd

Which company has a larger market capitalization, Indoco Remedies Ltd or Influx Healthtech Ltd?

Market cap of Indoco Remedies Ltd is 3,112 Cr while Market cap of Influx Healthtech Ltd is 304 Cr

What are the key factors driving the stock performance of Indoco Remedies Ltd and Influx Healthtech Ltd?

The stock performance of Indoco Remedies Ltd and Influx Healthtech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indoco Remedies Ltd and Influx Healthtech Ltd?

As of July 5, 2025, the Indoco Remedies Ltd stock price is INR ₹337.45. On the other hand, Influx Healthtech Ltd stock price is INR ₹131.35.

How do dividend payouts of Indoco Remedies Ltd and Influx Healthtech Ltd compare?

To compare the dividend payouts of Indoco Remedies Ltd and Influx Healthtech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions